Sections & Offices
| Delivering quality urological education | ||
 | At the last congress in Paris, I had the honour of being elected Adjunct Secretary General and the Executive Member for Education. Having served the European School of Urology (ESU) for eight years as Director, this marks the second time that I succeed Prof. Chris Chapple. He has previously also served the ESU as Director, and I can count on his support in my new position. | |
| ||
| ESOU’s Hamburg meeting: a comprehensive update on urological cancers | ||
 | A varied and comprehensive update on prostate, renal, bladder, penile and testis cancers will be presented and closely examined at the 9th Meeting of the EAU Section of Urological Oncology (ESOU) to be held in Hamburg, Germany, from April 20 to 22. | |
| ||
| What is your view on MRI in the management of PCa? | ||
 | We kindly ask you to take the 2012 survey of the EAU Section of Urological Imaging (ESUI). This will take no more than three minutes of your time. The survey addresses the current use of MRI in the management of PCa and the conformity of exams and reports with current recommendations. This information is of importance as MRI is playing an increasing role in the management of PCa. The results will be presented at this year’s EAU Congress in Paris. | |
| ||
| ESUR accepting nominations for D. Chopin Distinguished Award | ||
 | The EAU Section of Urological Research looks forward to honouring a researcher who has significantly advanced basic, translational or clinical urological research. The D. Chopin Award will be presented to a nominee based on the following criteria: | |
| ||
| Call for candidates for the ESUI Vision Award | ||
 | The EAU Section of Urological Imaging (ESUI) calls for candidates for the ESUI Vision Award, which will be given to the first author of the most innovative imaging study in urology published during the last year. | |
| ||
| Neuromodulation: Any progress? | ||
 | Neuromodulation of the sacral nerves has been introduced gradually from 1994 onwards and when Medtronic commercialised the Interstim devices. The introduction of the tined lead proved to be a major step in reducing the number of reinterventions. | |
| ||
| The GPIU study is now more important than ever | ||
 | The Global Prevalence Study of Infections in Urology (GPIU) is an annual initiative which runs successfully for eight years now. This study is a crucial tool in understanding the impact of infections in urology – and what is more important – it plays a preemptive role. The study maps out the situation as it progresses over the years, equipping the urological community with the knowledge and the data to be prepared for future developments, which, according to Prof. F. Wagenlehner, who coordinates this year’s study, is not all pained in bright colours. | |
| ||
| 6th ESOU Meeting: updates in onco-urology | ||
| Arnhem, January 2009 - The 6th Meeting of the European Society of Oncological Urology (ESOU) will be held in the Ceylan InterContinentall in Istanbul (TR), from 16 to 18 January 2009, with organisers presenting the latest updates on treatment strategies to onco-urology specialists. | ||
| ||
